Stock Taper
Quanterix Corporation develops digital immunoassay platforms and reagents for precision health research and diagnostics across global life sciences, serving academic, pharmaceutical, and biotech labs in neurology, oncology, cardiology, infectious ...

The Simoa HD-X Analyzer by Quanterix is the world's most sensitive fully automated immunoassay platform, enabling ultra-sensitive, multiplexed biomarker detection with up to 1000x greater sensitivity for neurology, oncology, and cardiology research.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $26.15M | $29.22M ▲ | $25.48M ▼ | $23.48M ▼ |
![]() | Consumable And Other Products | $18.95M | — | $21.38M ▲ | $19.82M ▼ |
![]() | Service And Other Revenue | $13.95M | $14.41M ▲ | $10.38M ▼ | $9.02M ▼ |
![]() | Instruments | $7.2M | — | $4.1M ▼ | $3.66M ▼ |
![]() | Research Services | $8.04M | — | $4.35M ▼ | $2.99M ▼ |
![]() | Other Services | $2.93M | — | $3.12M ▲ | $1.74M ▼ |
![]() | License and Service | $46K | $152K ▲ | $560K ▲ | $412K ▼ |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | North America | $13.93M | $14.94M ▲ | $13.51M ▼ | $11.6M ▼ |
![]() | EMEA | $8.11M | $10.03M ▲ | $8.03M ▼ | $8.02M ▼ |
![]() | Asia Pacific | $4.11M | $4.26M ▲ | $3.95M ▼ | $3.86M ▼ |
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
SGHT | $8.55 | COMPARE |
MASS | $10.73 | COMPARE |
SENS | $9.33 | COMPARE |
VMD | $8.82 | COMPARE |
IMRX | $4.99 | COMPARE |
INGN | $5.50 | COMPARE |
CVRX | $2.95 | COMPARE |
OM | $3.94 | COMPARE |